CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Seeking Alpha Healthcare
Original article

MannKind outlines $110M-$120M 2026 Furoscix revenue target as ReadyFlow ships in weeks

FuroscixReadyFlowPositive
AI Analysis

Summary

MannKind provided 2026 revenue guidance of $110M-$120M for Furoscix and announced that ReadyFlow is expected to ship within weeks.

Financial Highlights

Guidance

$110M-$120M 2026 Furoscix revenue target

Importance:5/10
Sentiment:
0.60
revenue guidanceproduct launchFuroscixReadyFlow
Related Companies

Read the original article

Published by Seeking Alpha Healthcare on August 6, 2026 3:30 AM

Read Original